Alopecia (Hair Loss)Treatment Market - Segments, Dynamics, Size and Forecast (2016 - 2022)
Transcription
Alopecia (Hair Loss) Treatment Market - Segments, Dynamics, Size and Forecast (2016 - 2022) Persistence Market Research Alopecia (Hair Loss)Treatment Market Segments, Dynamics, Size and Forecast (2016 - 2022) Persistence Market Research 1 Alopecia (Hair Loss) Treatment Market - Segments, Dynamics, Size and Forecast (2016 - 2022) Persistence Market Research Released New Market Report on “Alopecia (Hair Loss)Treatment Market - Segments, Dynamics, Size and Forecast (2016 - 2022)”. Alopecia is a term used to describe excessive hair damage under certain medical conditions or dietary issues. Sedentary lifestyle, and unhealthy diets is leading to loss of hair among masses. Furthermore, ageing and hormonal imbalance, increasing chronic disease like arthritis, cancer, hypertension, depression also leads to hair loss especially among middle aged population. According to American Hair Loss Association, androgenetic alopecia accounts for over 95% of hair loss in men. Over 800 thousand patients are seeking some kind of treatment for hair loss worldwide. For the treatment of alopecia, U.S. FDA proved two drugs - Minoxidil, to treat hypertension and finasteride (Propecia) to treat benign prostate hyperplasia (BPH). American Hair Loss Association recommends the use of minoxidil in patients who have not responded to finasteride treatment. Prevalence rate of alopecia is high among working age population. Treatment seeking rate for alopecial is more prevalent in developed regions as compared to that in developing regions, however, over the past few years, demand for alopecia treatment has increased dramatically in developing regions such as China and India owing to increase in healthcare expenditure and improved healthcare infrastructure facilities. In China, 6 percent females and 21 percent of males suffer from hormone driven hair loss. Changing lifestyle along with increase in stress level among working class population is expected to boost the demand for treatment of hair loss globally. Furthermore, rise in geriatrics population along with high demand for surgical hair transplant is expected to drive the alopecia treatment market. Increasing consumer disposable incomes and health awareness, emphasis to look good, and technological advancement in hair treatment medical devices are some other key drivers for this market. Since accessibility for scalp treatment is easily accessible and available, the demand for alopecia treatment has increased. Persistence Market Research 2 Alopecia (Hair Loss) Treatment Market - Segments, Dynamics, Size and Forecast (2016 - 2022) Though the market is expected to witness healthy growth during the forecast period, high cost of the medications and possible side effects/allergic reactions are acting as key barrier for alopecia market. Alopecia Treatment Market is broadly classified on the basis of the following segments – Alopecia Treatment Market by Product: • Vitamins and Supplements • Shampoos and Conditioners • Others (Serums, gels and oils) Alopecia Treatment Market by Gender: • Men • Women • Children Alopecia Treatment Market by End User: • Homecare Settings • Dermatology Clinics • Others (Salons) The alopecia treatment market has grown substantially at a healthy CAGR due to changing lifestyle and greater emphasis on outward appearance to look good. With rapid technological advancement and innovation, alopecia treatment market is expected to grow globally. North Persistence Market Research 3 Alopecia (Hair Loss) Treatment Market - Segments, Dynamics, Size and Forecast (2016 - 2022) America is the largest market for alopecia treatment while Asia Pacific is expected to be the fastest growing market during the forecast period. Interested in report: Please follow the below links to meet your requirements; Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/9677 The alopecia treatment market is expected to register a significant CAGR during the forecast period. Depending on geographic regions, alopecia treatment is segmented into seven key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America, followed by Europe, is expected to dominate the alopecia treatment market throughout the forecast period. Asia Pacific excluding Japan is poised to witness fastest growth owing to outburst of middle aged population in the region. Also, the region is witnessing healthy growth in terms of GDP, which in turn is expected to propel growth at healthy digits. Middle East & Africa and Latin America are expected to sluggish growth during the forecast period. Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/9677 Some of the key market players for alopecia treatment market are Cipla, Viviscal, Dr. Reddy’s Laboratories Ltd., Regaine, Merck & Co., Inc, Ranbaxy Laboratories Ltd, Phyto - Alès Groupe, Kirkland Signature, Vitabiotics, Nanogen, Alpecin - Dr. Kurt Wolff GmbH & Co. KG, Rogaine Johnson and Johnson. The report covers exhaustive analysis on: • Alopecia Treatment Market Segments • Alopecia Treatment Market Dynamics Persistence Market Research 4 Alopecia (Hair Loss) Treatment Market - Segments, Dynamics, Size and Forecast (2016 - 2022) • Historical Actual Market Size, 2013 - 2015 • Alopecia Treatment Market Size & Forecast 2016 to 2022 • Alopecia Treatment Market Current Trends/Issues/Challenges • Competition & Companies involved • Alopecia Treatment Market Drivers and Restraints For more info: http://www.persistencemarketresearch.com/contact-us.asp Regional analysis includes • North America • Latin America • Europe • Asia Pacific • Middle East and Africa Report Highlights: • Shifting Industry dynamics • In-depth market segmentation • Historical, current and projected industry size • Recent industry trends • Key Competition landscape • Strategies of key players and product offerings Persistence Market Research 5 Alopecia (Hair Loss) Treatment Market - Segments, Dynamics, Size and Forecast (2016 - 2022) • Potential and niche segments/regions exhibiting promising growth • A neutral perspective towards market performance About Us: Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs. PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values. Contact Us: Persistence Market Research 305 Broadway, 7th Floor, New York City, NY 10007, United States. Phone: +1-646-568-7751 USA/Canada Toll Free Number: +1-800-961-0353 E-mail: [email protected] Web : http://www.persistencemarketresearch.com Persistence Market Research 6
Similar documents
Screen Less Display Market - Global Industry Analysis and Forecast 2016 - 2022
The key trend responsible for the growth of global screen less display is the implementation and innovation of this technology is being done by almost all the major manufacturers of electronic smart gadgets. The key growth drivers of global screen less display market are; space constraints and portability issue of smart gadgets with touch screen display, whereas screen less technology gives relief with limitations related to bulkiness and heavy weight.
More informationAsia Pacific Alopecia Treatment Market, 2016 - 2024
Alopecia is a prevalent autoimmune disorder, resulting in loss of hair all over the body, predominantly on the scalp. It usually starts with one or smaller round patches on the scalp (alopecia areata) and progresses to total scalp hair loss (alopecia totalis), or complete body hair loss (alopecia universalis). Alopecia universalis is the least prevalent autoimmune disorder, affecting less than 5% of total population with alopecia.
More information